OrganaBio expands cell therapy manufacturing footprint with acquisition of Excellos Assets
The deal also establishes a new subsidiary, Excellos Labs, which will oversee continued operations in San Diego
The deal also establishes a new subsidiary, Excellos Labs, which will oversee continued operations in San Diego
Union health ministry secretary Punya Salila Srivastava lauds HLL’s six decades of contribution to public healthcare and social development
The country’s strength lies not just in technology availability but in adoption behaviour
Doshi has established a strong track record in driving quality assurance, regulatory compliance, and formulation excellence across complex pharmaceutical operations
Despite the strong results, investigators cautioned that the study has limitations, including its open-label Phase II design, lack of randomization, and reliance on a historical external control arm
Access to genomic testing, not therapy cost, is the biggest challenge
At the institute's 42nd convocation ceremony, Union Minister described its eight-institution MoU initiative as a unique collaborative effort that brings together premier national institutions to create a synergistic research ecosystem
Medanta expanded its bed capacity by 20% during the year
The move signals a strategic pivot toward deeper integration between clinical leadership and medical technology developers
Famotidine Injection USP is a generic version of Pepcid injection to be manufactured at its Nagpur facility for the U.S. market
Subscribe To Our Newsletter & Stay Updated